Bills · HR 6789
IN COMMITTEE· 119TH CONGRESS
House BillHR 6789Crime and Law Enforcement
Federal Prisons Naloxone Access Act of 2025
INTRO DEC 17· LAST ACTION DEC 17
READING
4MIN
COSPONSORS
4
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because opioid overdoses are a significant public health crisis, and this issue extends into correctional facilities where rates of substance use disorder can be high. If passed, this bill would directly address the risk of fatal overdoses in federal prisons by ensuring quick access to life-saving medication and training. Without this bill, access to these medications might remain inconsistent or limited, potentially leading to preventable deaths.
By making naloxone widely available and empowering both staff and incarcerated persons with training, the bill aims to create a safer environment within federal prisons and reduce the number of overdose fatalities. It reflects a growing recognition that substance use disorder is a medical condition and that harm reduction strategies can save lives, even in carceral settings.
KEY PROVISIONS
5AI-extractedPROVISION 01
Requires federal prisons to keep an "adequate number" of opioid overdose reversal kits in many areas, including medical units, staff breakrooms, visiting areas, living quarters, and any place people gather.
Ensures that life-saving medication is widely and easily accessible throughout the prison, not just in limited medical settings, allowing for rapid response to overdoses.
PROVISION 02
Mandates annual training for both federal prison staff and incarcerated individuals on how to recognize opioid overdoses and properly administer the reversal medication.
Empowers both staff and incarcerated people to act quickly in an overdose emergency, increasing the likelihood of survival.
PROVISION 03
Protects incarcerated individuals from legal liability if they administer an opioid overdose reversal kit in good faith.
Encourages incarcerated people to intervene in an overdose situation without fear of punishment, potentially saving lives.
PROVISION 04
Requires the Bureau of Prisons to report annually to Congress on various aspects of the program, including the number of kits, overdoses, and trainings.
Provides accountability and transparency, allowing Congress and the public to monitor the effectiveness and compliance of the program.
PROVISION 05
Authorizes specific funding for the program, with $6 million in fiscal year 2026 and $2 million for each of fiscal years 2027 and 2028.
Ensures that the Bureau of Prisons has dedicated resources to implement the new requirements for purchasing medication, training, and reporting.
SPONSORSHIP
1 + 4
D· North Carolina
YRS IN OFFICE
3
BILLS LED
38
COSPONSOR BREAKDOWNBIPARTISAN · 0%
DEM 4 REP 0 IND 0
ACTION TIMELINE
2 EVENTSDEC 17
Introduced in House
DEC 17
Referred to the House Committee on the Judiciary.
BILL INFO
TypeHouse Bill
NumberHR 6789
Congress119th
StatusIn Committee
IntroducedDec 17, 2025
Last actionDec 17, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · JUDICIARY COMMITTEE · INTRODUCED DEC 17, 2025
House BillHR 6789Crime and Law Enforcement
Federal Prisons Naloxone Access Act of 2025
INTRODUCED DEC 17, 2025· LAST ACTION DEC 17, 2025
PASSAGE CHANCES
—%
READING
4 min
COSPONSORS
4
COMPLEXITY
Moderate
